Global Animal Microbiome Market Size is valued at USD 7.2 Billion in 2024 and is predicted to reach USD 19.2 Billion by the year 2034 at a 10.6% CAGR during the forecast period for 2025-2034.
Animal Microbiomes are referred to as the communities of microorganisms such as viruses, bacteria, and fungi that symbiotically live around, on, and in animals which contribute to animal well-being and health. Microbiomes in animals are key to maintaining the healthy function of their diverse ecosystems. Animal Microbiomes find the critical range of application in Poultry, Ruminants, Swine, Aquaculture, and Pets. By region, In 2021, Asia Pacific dominates the market with a share of 35.4% of the global Animal Microbiome market. China and India are the key markets holding the majority of the market for Animal Microbiome in the region.
The global poultry and livestock population is anticipated to rise in the next couple of years to a significant extent. According to the USDA Foreign Agricultural Service report 2019, world cattle inventory is anticipated to be around 1,001,841,000. The market is primarily driven by the rising livestock population and the domestic animal trend is especially prominent in developing countries such as China, India, and Brazil. India has the largest cattle population with approximately 30.4% of global cattle inventory. China has positioned itself as a world leader in pork production, and its animal-derived dietary production has increased from less than 70 million tons in 2010 to more than 76 million tons in 2016. The rapid increase in research and development in the animal microbiome industry along with rising awareness about antibiotic-free animal-derived products for animal health and wellbeing has been seen in recent years has further created significant market opportunities in upcoming years.
Market Segmentation
The global Animal Microbiome market is segmented on the basis of product, application, and region. Based on the products, the market is divided into Therapeutic/Pharma Products, Phage Therapy Product, Functional Food, Medical Food, and Dietary Supplement. On the basis of application type, the market is segmented into Poultry, Ruminants, Swine, Aquaculture, and Pets. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that, Europe held the largest share of the market, followed by America and the Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of the forecast period.
Competitive Landscape
Some Of The Key Players In The Animal Microbiome Market:
- Animal Biome, Inc.,
- ANIZOME LLC,
- Cargill,
- Hansen Holding A/S,
- Cytophage Technologies Inc.,
- DuPont Industrial Biosciences,
- Elanco Animal Health,
- EnBiotix, Inc.,
- Gnubiotics Sciences SA,
- Hill's Pet Nutrition, Inc.,
- Intralytix,
- Koninklijke DSM N.V. (Royal DSM),
- Lallemand Inc.,
- Land O'Lakes, Inc.,
- Leiber GmbH,
- MicroSintesis,
- NomNomNow Inc.,
- Novozymes A/S,
- Orion Pharma Animal Health,
- Phage Technologies SA,
- Phagelux, Inc.,
- Phibro Animal Health Corporation,
- ProDigest,
- Tonicity International Limited,
- VetoPhage
The Animal Microbiome Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 7.2 Billion |
|
Revenue Forecast In 2034 |
USD 19.2 Billion |
|
Growth Rate CAGR |
CAGR of 10.6% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, By Application, By Animal Type |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Animal Biome, Inc., ANIZOME LLC, Cargill, Chr. Hansen Holding A/S, Cytophage Technologies Inc., DuPont Industrial Biosciences, Elanco Animal Health, EnBiotix, Inc., Gnubiotics Sciences SA, Hill's Pet Nutrition, Inc., Intralytix, Koninklijke DSM N.V. (Royal DSM), Lallemand Inc., Land O'Lakes, Inc., Leiber GmbH, MicroSintesis, NomNomNow Inc., Novozymes A/S, Orion Pharma Animal Health, Phage Technologies SA, Phagelux, Inc., Phibro Animal Health Corporation, ProDigest, Tonicity International Limited, and VetoPhage. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
